Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polypill for Primary Prevention of Cardiovascular Disease (Sri Lanka Pilot)
NCT00567307Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2009
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
A Phase 2 trial of Red Heart Pill 2b in cardiovascular disease (CVD), sponsored by Wake Forest University Health Sciences. Started Jan 2009; status: completed.
02
Drugs
Red Heart Pill 2b
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00567307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567307.